<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS136600</article-id>
<article-id pub-id-type="doi">10.1101/2021.10.11.463917</article-id>
<article-id pub-id-type="archive">PPR406670</article-id>
<article-version article-version-type="publisher-id">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Secondary structure of subgenomic RNA M of SARS-CoV-2</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Soszynska-Jozwiak</surname>
<given-names>Marta</given-names>
</name>
<email>mjozwiak@ibch.poznan.pl</email>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kierzek</surname>
<given-names>Ryszard</given-names>
</name>
<email>rkierzek@ibch.poznan.pl</email>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kierzek</surname>
<given-names>Elzbieta</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland</aff>
<author-notes>
<corresp id="CR1">
<label>*</label>Elzbieta Kierzek, Institute of Bioorganic Chemistry Polish Academy of Sciences, Poland, <email>elzbieta.kierzek@ibch.poznan.pl</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>10</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="preprint">
<day>12</day>
<month>10</month>
<year>2021</year>
</pub-date>
<permissions>
<ali:free_to_read/>
<license>
<ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">SARS-CoV-2 belongs the <italic>Coronavirinae</italic> family. As other coronaviruses, SARS-CoV-2 is enveloped and possesses positive-sense, single-stranded RNA genome of ~30 kb. Genome RNA is used as the template for replication and transcription. During these processes, positive-sense genomic RNA (gRNA) and subgenomic RNAs (sgRNAs) are created. Several studies showed importance of genomic RNA secondary structure in SARS-CoV-2 replication. However, the structure of sgRNAs have remained largely unsolved so far. In this study, we performed probing of sgRNA M of SARS-CoV-2 <italic>in vitro</italic>. This is the first experimentally informed secondary structure model of sgRNA M, which presents features likely to be important in sgRNA M function. The knowledge about sgRNA M provides insights to better understand virus biology and could be used for designing new therapeutics.</p>
</abstract>
<kwd-group>
<kwd>RNA structure</kwd>
<kwd>SARS-CoV-2</kwd>
<kwd>COVID-19</kwd>
<kwd>subgenomic RNAs</kwd>
<kwd>sgRNA</kwd>
<kwd>sgRNA M</kwd>
<kwd>chemical mapping</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P2">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes Coronavirus disease 19 (COVID-19) and is responsible for infecting a large number of people all over the word, resulting in death of many people, especially among older. Moreover, SARS-CoV-2 causes disruptions to health service, travel, trade, education as well as has a negative impact on people’s physical and mental health [<xref ref-type="bibr" rid="R1">1</xref>]. SARS-CoV-2 belongs to the Betacoronavirus genus and is a member of the <italic>Coronavirinae</italic> family which also includes alpha-, gamma- and deltacoronaviruses [<xref ref-type="bibr" rid="R2">2</xref>]. As other coronaviruses, SARS-CoV-2 is enveloped, and possess three structural proteins: membrane protein (M), spike protein (S), and envelope protein (E), while nucleocapsid protein (N) protects viral RNA genome by forming a capsid [<xref ref-type="bibr" rid="R3">3</xref>]. SARS-CoV-2 also contains sixteen non-structural proteins (nsp1–16) and accessory proteins [<xref ref-type="bibr" rid="R4">4</xref>], [<xref ref-type="bibr" rid="R5">5</xref>]. SARS-CoV-2 represent RNA viruses and possess positive-sense, single-stranded RNA genome of ~30 kb [<xref ref-type="bibr" rid="R6">6</xref>]. The genomic RNA has a 5’ cap and 3’ polyA tail and is used for translation to produce two large overlapping polyproteins (pp): pp1a and pp1ab. Polyproteins pp1a and pp1ab contain the nsps 1–11 and 1–16, respectively. Many of them with N protein create replicase-transcriptase complex (RTC) [<xref ref-type="bibr" rid="R7">7</xref>]. Genome RNA is used as the template for replication and transcription by RTC. These processes result in generation negative-sense RNA intermediates, that serve as temple for production positive-sense genomic RNA (gRNA) and subgenomic RNAs (sgRNAs). The gRNA is packaged to progeny virions or is used for translation, while sgRNAs encode conserved structural proteins, nucleocapsid protein and several accessory proteins [<xref ref-type="bibr" rid="R8">8</xref>]–[<xref ref-type="bibr" rid="R11">11</xref>].</p>
<p id="P3">Each sgRNA possesses a short 5’-terminal leader sequence derived from the 5’ end of the genome. Transcription regulatory sequences (TRS) is necessary to add leader sequence to sgRNA [<xref ref-type="bibr" rid="R12">12</xref>]. TRS is located at the 3’ end of the leader sequence (leader TRS, TRS-L), as well as TRSs are located upstream of the genes in the 3’-proximal part of the genome (body TRSs, TRS-B). TRSs contain a conserved 6–7 nt core sequence (CS) surrounded by variable sequences. During negative-strand synthesis, RNA-dependent RNA polymerase (RdRP) pauses when it crosses a body TRS and switches the template to leader TRS. As a result sgRNA possess a leader sequence derived from the 5’ untranslated region of the genome and a TRS 5’ of the open reading frame [<xref ref-type="bibr" rid="R13">13</xref>], [<xref ref-type="bibr" rid="R14">14</xref>].</p>
<p id="P4">RNA secondary structure of untranslated and coding regions play a key role in viral replication cycle [<xref ref-type="bibr" rid="R15">15</xref>]. Secondary structure of RNA of SARS-CoV-2 has been intensively studied. Bioinformatic analysis showed that SARS-CoV-2 genome has almost twice the propensity to form secondary structure than one of the most structured RNA genomes in nature [<xref ref-type="bibr" rid="R16">16</xref>]. Recently, detailed secondary structure models for the extended 5’ UTR, frameshifting stimulation element, 3’ UTR and regions of the SARS-CoV-2 viral genome that have low propensity for RNA secondary structure and are conserved within SARS-CoV-2 strains were predicted [<xref ref-type="bibr" rid="R17">17</xref>] [<xref ref-type="bibr" rid="R18">18</xref>]. SARS-CoV-2 was also investigated for the presence of large-scale internal RNA base pairing (genome-scale ordered RNA structure) (GORS)) in its genome. This analysis showed existence of 657 stem-loops structures and 2015 duplexes [<xref ref-type="bibr" rid="R19">19</xref>]. Data revealed that regions containing the highest amount of structure of SARS-CoV-2 genome are the 5’ end as well as regions corresponding to glycoproteins spike S and membrane M [<xref ref-type="bibr" rid="R20">20</xref>]. Lately, RNA structure probing of the full SARS-CoV-2 coronavirus genome both <italic>in vitro</italic> and in living infected cells was published [<xref ref-type="bibr" rid="R21">21</xref>]–[<xref ref-type="bibr" rid="R24">24</xref>]. Recently, using RNA structure probing with Nanopore direct-RNA sequencing, NAI reactivity of 3a, E, M, 6, 7a, 7b, 8 and N sgRNAs were measured [<xref ref-type="bibr" rid="R25">25</xref>]. However, the structure model of sgRNA M has not been determined and discussed so far.</p>
<p id="P5">In this study, we performed probing of the model of sgRNA M of SARS-CoV-2 <italic>in vitro</italic>. We use SHAPE method and chemical mapping with DMS and CMCT to obtain secondary structure of sgRNA M. This is the first experimentally informed secondary structure model of sgRNA M, which presents features likely to be important in sgRNA M function. A full set of chemical reagents allow to predict high accuracy structure. A comprehensive understanding of sgRNA M structure will provide important insights to better understand virus biology and could be used for designing new therapeutics.</p>
</sec>
<sec id="S2" sec-type="results | discussion">
<title>Results and Discussion</title>
<sec id="S3">
<title>Secondary structure of sgRNA M of SARS-CoV-2</title>
<p id="P6">Model of subgenomic RNA M of SARS-CoV-2 (sgRNA M) was obtained by adding leader sequence to M coding sequence from the SARS-CoV-2 strain Slovakia/SK-BMC5/2020 using PCR reactions. This process allowed achieving RNA with “leader to body fusion” that is characteristic for sgRNA of Coranaviridae family and taking place during transcription [<xref ref-type="bibr" rid="R14">14</xref>]. Chemical mapping was used to determine secondary structure of sgRNA M. <italic>In vitro</italic> transcribed sgRNA M was folding in folding buffer (300mM NaCl, 5mM MgCl<sub>2</sub>, 50mM HEPES, pH 7.5) to obtain single RNA conformation, as assessed by non-denaturing agarose gel. Chemical mapping was performed at 37°C with DMS (methylates N1 of A and N3 of C when unpaired), CMCT (modifies N3 of U and N1 of G when unpaired) and NMIA (SHAPE method, modified flexible 2’-hydroxyl of ribose) [<xref ref-type="bibr" rid="R26">26</xref>][<xref ref-type="bibr" rid="R27">27</xref>][<xref ref-type="bibr" rid="R28">28</xref>]. The data from chemical mapping were analyzed by reverse transcription followed by capillary electrophoresis.</p>
<p id="P7">DMS modified strongly 123 nucleotides (nt), meaning that 32.6% of all adenosines and cytidines in sgRNA M were structurally accessible. CMCT modified 106 nts, which represents 40.9% of all uridines. The SHAPE reagent NMIA modified strongly 119 nts and 56 nts undergo moderate modifications, that is together 22.2% of sgRNA M nucleotides. Chemical mapping data and SHAPE data are complementary to each other and show eight the most flexible regions (each containing at least 7 flexible nucleotides in sequence): 36-43, 76-86, 260-267, 469-481, 487-494, 596-603, 612-621, 729-743 (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
</sec>
<sec id="S4">
<title>Base pair probabilities</title>
<p id="P8">To assess prediction quality and identify well-defined structural regions we calculated the secondary structure partition function using RNAstructure 6.2 and, from this, determined the base pair probabilities for model pairs [<xref ref-type="bibr" rid="R29">29</xref>]. For the partition function calculations, experimental data were included. Results indicate that there are several regions with paired and unpaired nucleotides of more than 90% probability: 1-121, 131-210, 220-502, 707-766. Additionally, all single stranded regions are well defined by having low probability of pairing (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
</sec>
<sec id="S5">
<title>Model of secondary structure of sgRNA M</title>
<p id="P9">To predict the secondary structure of sgRNA M based on the experimental probing data, the results of chemical mapping were used to constrain predictions in the RNAstructure 6.2 program. SHAPE data were loaded as pseudoenergy constraints (the energy contribution of SHAPE reactive nt were penalized) and DMS, and CMCT modifications were included as chemical mapping constraints (reactive nt are forbidden to be in Watson-Crick base pairs flanked by Watson-Crick base pairs).</p>
<p id="P10">Model of sgRNA M is highly structured with plenty of accessible bulges and loops (<xref ref-type="fig" rid="F1">Figure 1</xref>). RNA motifs of sgRNA M model are thermodynamically stable (dG=- 418,5 kcal/mol) and have high calculated base pair probability. We showed that most of the inaccessible regions by chemical mapping, correspond to areas containing base pairs. 5’end of the sgRNA M model was folded in three hairpins: SL1, SL2, SL3. This three hairpins also occurs in 5’UTR of SARS-CoV-2 in its 5’ 300 nt fragment [<xref ref-type="bibr" rid="R21">21</xref>], [<xref ref-type="bibr" rid="R30">30</xref>], [<xref ref-type="bibr" rid="R31">31</xref>], in <italic>in vitro</italic> model of whole genome and also in-cell model [<xref ref-type="bibr" rid="R21">21</xref>]–[<xref ref-type="bibr" rid="R24">24</xref>], [<xref ref-type="bibr" rid="R32">32</xref>]. These hairpins are also in good agreement with structural–phylogenetic analysis of group IIb coronaviruses [<xref ref-type="bibr" rid="R4">4</xref>] and <italic>in silico</italic> prediction of whole SARS-CoV-2 genome [<xref ref-type="bibr" rid="R17">17</xref>], [<xref ref-type="bibr" rid="R18">18</xref>]. Moreover, folding of a 5’ leader sequence of sgRNA M is in agreement with study of secondary structure of subgenomic RNA N [<xref ref-type="bibr" rid="R16">16</xref>]. This investigation showed that 5’ leader sequence folds almost autonomously in the sgRNA N, with the exception of a few poorly determined long-range interactions [<xref ref-type="bibr" rid="R16">16</xref>]. SL1 is the most variable among SARS-CoV-2 variants [<xref ref-type="bibr" rid="R30">30</xref>], generally possessing mismatches, bulges and a high number of A–U and U–A base pairs. This fact causes less thermodynamically stability of SL1 than SL2 and SL3. On the other hand, this feature is important for the replication of Mouse hepatitis virus (MHV), well-studied members of coronaviridae family [<xref ref-type="bibr" rid="R33">33</xref>]. SL2 is conserved in all CoVs, typically containing a pentaloop stacked on a 5 base-pair stem and creating U-turn motif. This hairpin plays a critical role in MHV replication and translation [<xref ref-type="bibr" rid="R34">34</xref>]. SL3 is conserved only in subgroups of beta and gammaCoV [<xref ref-type="bibr" rid="R4">4</xref>] and contains TRS-L sequences, that take part in discontinuous transcription [<xref ref-type="bibr" rid="R4">4</xref>], [<xref ref-type="bibr" rid="R13">13</xref>].</p>
<p id="P11">Recently, prediction of interaction between SARS-CoV-2 genome and human proteome indicated that highly structured region at the 5’ end had the large number of interactions with proteins such as 1) ATP-dependent RNA helicase - DDX1, that was previously reported to be essential for Avian infectious bronchitis coronavirus replication [<xref ref-type="bibr" rid="R35">35</xref>] and 2) ADAR double-stranded RNA-specific editases, that catalyse the hydrolytic deamination of adenosine to inosine, result in affecting viral protein synthesis, proliferation and infectivity [<xref ref-type="bibr" rid="R36">36</xref>], and 3) 2’-5’-oligoadenylate synthetases that control viral RNA degradation [<xref ref-type="bibr" rid="R20">20</xref>], [<xref ref-type="bibr" rid="R37">37</xref>], [<xref ref-type="bibr" rid="R38">38</xref>]. Some of these proteins could interact with a leader sequence of sgRNA. This fact confirmed experiments with DDX1 knockdown that reduced the number of sgRNA in SARS-CoV-1 infected cells [<xref ref-type="bibr" rid="R39">39</xref>]. These finding and preservation of 5’UTR motifs in sgRNA M could indicate the similar interactions with sgRNA M. Moreover, interactions between SARS-CoV-2 genome as well as sgRNAs and host RNAs were revealed. However, SAR-CoV-2 genome and sgRNAs take part in different interactions with host RNAs [<xref ref-type="bibr" rid="R25">25</xref>], [<xref ref-type="bibr" rid="R32">32</xref>].</p>
<p id="P12">Generally, presented model of secondary structure of sgRNA M and its corresponding region of the whole SARS-CoV-2 genome obtained by probing <italic>in vivo</italic> [<xref ref-type="bibr" rid="R22">22</xref>] are different (<xref ref-type="fig" rid="F3">Figure 3</xref>). It is in agreement with previous study about <italic>in vivo</italic> RNA-RNA interactome of the full-length SARS-CoV-2 genome and several subgenomic mRNAs. This investigation revealed that the viral genome and subgenomes adopt alternative topologies inside cell [<xref ref-type="bibr" rid="R32">32</xref>]. However, some regions in the presented model of sgRNA M fold in the same structure as in genome M region in infected cells. Motifs: 153-167, 178-198, 223-259, 299-329, 340-351/447-458, 362-435, 484-498, 514- 592, 604-698, 712-759 are consistent with in-cell secondary structure model of SARS-CoV-2 genome [<xref ref-type="bibr" rid="R22">22</xref>]. However, hairpin 514-592 is longer about 3 base pairs and possesses an additionally internal loop in-cell model. In turn, hairpins 131-150 and 281-297 are almost identical to that of corresponding region of SARS-CoV-2 genome that was mapped in cells [<xref ref-type="bibr" rid="R22">22</xref>]. In our model, loops are longer than corresponding region in-cell model. On the other hand, small motif 503-512 is only hairpin-structure characteristic for sgRNA M, and does not exist in SARS-CoV-2 genome. Determined sgRNA M secondary structure is also similar to corresponding regions of other published whole genome of SARS-CoV-2 models [<xref ref-type="bibr" rid="R23">23</xref>, <xref ref-type="bibr" rid="R24">24</xref>]. This similarity between sgRNA M structure and in-cell determined structure of fragment M in whole genome context is surprising due to the fact that RNA structure <italic>in vitro</italic> and <italic>in vivo</italic> could be significantly different. <italic>In vivo</italic> interaction between RNA and proteins or other molecules can influence secondary structure [<xref ref-type="bibr" rid="R40">40</xref>]. This data indicated that the sequence and thermodynamics alone are major determinants of sgRNA M motifs formation. All these results point to these stable motifs being functionally significant. Furthermore, experiments and computational analysis have shown that large amounts of double-stranded regions have a strong propensity to interact with proteins and act as scaffolds for RNA-binding proteins [<xref ref-type="bibr" rid="R41">41</xref>]–[<xref ref-type="bibr" rid="R43">43</xref>]. sgRNA M is very structured and it is possible for stable helices to interplay with proteins.</p>
</sec>
<sec id="S6">
<title>Local structural motifs in sgRNA M are mostly independent of leader sequence</title>
<p id="P13">We compared our sgRNA M model with the corresponding region of <italic>in vitro</italic> model of whole SARS-CoV-2 genome [<xref ref-type="bibr" rid="R21">21</xref>] to check the influence of 5’leader sequence on folding of subgenomic RNA. We indicated that the structures are different. This feature is consistent with study with subgenomic RNA N and its corresponding region in SARS-CoV-2 genome. This data indicated that the same RNA sequences can fold in different structures in the subgenomic and genomic contexts [<xref ref-type="bibr" rid="R16">16</xref>]. However, some local motifs (131-150, 153-167, 181-194, 223-259, 267-279/102-114, 280-297, 299-329, 331-335/101-105, 340-358/439-458, 372-426, 483-499, 514-592, 604-698, 712-758 within the subgenomic RNA and SARS-CoV-2 genome are identical. Motifs 604-698 is slightly different in both models. Similar motifs are stable independently of the neighbouring regions (leader sequence in sgRNA M and sequences upstream/downstream of the M region in SARS-CoV-2 genome). It is possible that the existence and appropriate folding of neighbouring region has some, but relatively small, influence on some local motifs of sgRNA M. Some local structure motifs are identical within <italic>in vitro</italic> and <italic>in vivo</italic> SARS-CoV-2 genome models [<xref ref-type="bibr" rid="R21">21</xref>].</p>
</sec>
</sec>
<sec id="S7" sec-type="conclusions">
<title>Conclusion</title>
<p id="P14">The presented herein for the first time experimentally driven secondary structure of sgRNA M contains unique features likely to be important for its functions. The structure includes also several the same distinct motifs as genomic M fragment of SARS-CoV-2 genome. The new knowledge about sgRNA M provides insights to better understand virus biology and could be used for anti-SARS-CoV-2 strategies and designing new therapeutics.</p>
</sec>
<sec id="S8" sec-type="materials | methods">
<title>Material and Method</title>
<sec id="S9">
<title>Experimental Constructs</title>
<p id="P15">DNA temples for synthesis of sgRNA M was obtained in several steps. Firstly, reverse transcription was carried out using SuperScript III (Thermo Fisher Scientific) with Random Primers Mix (New England BioLabs) on RNA of SARS-CoV-2 from stain Slovakia/SK-BMC5/2020 (received from <ext-link ext-link-type="uri" xlink:href="https://www.european-virus-archive.com">https://www.european-virus-archive.com</ext-link>). Next, three PCR reactions using cDNA as template and specific primers (F1 and RM, F2 and RM, F3 and RM, Table) were done to add leader sequence and transcription promoter on 5’ end of sgRNA M. After this steps, primers FC, RC were used to add EcoRI site on 5’ end and Pst I site on 3’ end of template of M. DNA was purified using Pure Link ™ PCR Micro Kit (Thermo Fisher Scientific). The DNA template was cloned into pUC19 and sequenced using the M13F, M13R for confirmation of proper sequence (Table).</p>
</sec>
<sec id="S10">
<title>Oligonucleotides synthesis and labelling</title>
<p id="P16">Primers for reverse transcription were synthesized by the phosphoramidite approach on MerMade synthesizer. Primers for reverse transcription were synthesized with fluorophores: 5-FAM and 6-JOE on 5’-end (Table 2).Primers were deprotected and purified according to published protocols [<xref ref-type="bibr" rid="R44">44</xref>] [<xref ref-type="bibr" rid="R45">45</xref>]. Concentrations of all oligonucleotides were measured using a Spectrophotometer UV (NanoDrop2000 Thermo Scientific). Primers for PCR were purchase from Sigma-Aldrich.</p>
</sec>
<sec id="S11">
<title>RNA synthesis</title>
<p id="P17">DNA template for <italic>in vitro</italic> transcriptions of sgRNA M was obtained by PCR from plasmid puC19 using primers FM, RM (Table). DNA was purified using Pure Link ™ PCR Micro Kit (Thermo Fisher Scientific). <italic>In vitro</italic> transcription reaction was performed using a MEGAscript™ T7 Transcription Kit (Thermo Fisher Scientific) according to manufacture protocol. Product was purified using RNeasy MiniElute Cleanup Kit (Qiagen). Integrity and purity of samples were checked on agarose gel.</p>
</sec>
<sec id="S12">
<title>RNA folding</title>
<p id="P18">Before each experiment RNA was folded in the same manner. RNA was heated to 80°C in water for 5 min. and slowly cooled to 50°C. At this temperature 2-times concentrated folding buffer was added and samples were slowly cooled to 37°C. Final buffer contained 300 mM NaCl, 5 mM MgCl<sub>2</sub>, 50 mM HEPES, pH 7.5. Folding was analysed by native gel electrophoresis using 0.8% agarose gel running at 4 °C with low voltage. Under these conditions, one band was observed (<xref ref-type="supplementary-material" rid="SD1">Supporting_Information_2</xref>).</p>
</sec>
<sec id="S13">
<title>Chemical mapping using NMIA, DMS and CMCT</title>
<p id="P19">Folding of RNA was carried out as described above. Next, chemical mapping was conducted according to published procedures with appropriate optimizations [<xref ref-type="bibr" rid="R26">26</xref>] [<xref ref-type="bibr" rid="R27">27</xref>] [<xref ref-type="bibr" rid="R28">28</xref>]. Briefly, 5.6 mM of NMIA (N-methylisatoic anhydride) or 30 mM of CMCT (1-cyclohexyl-(2-morpholinoethyl) carbodiimide metho-p-toluene sulfonate) or 0.18% of DMS (dimethyl sulfate) were used in mapping reactions. Chemical mapping was performed at 37°C with DMS, CMCT or NMIA for 15, 30 or 40 min, respectively. Parallel, control reactions were done in the same condition but without mapping reagents. Modified nucleotides were read-out by primer extension using a stoichiometry of 2 pmol primer/2 pmol RNA. Primer extension was performed at 55°C with reverse transcriptase SuperScript III (Thermo Fisher Scientific) using manufacturer’s protocol. Next, cDNA fragments and ddNTP ladders were separated by capillary electrophoresis (Laboratory of Molecular Biology Techniques at Adam Mickiewicz University in Poznan). Primers labeled with 6-FAM were used for detection of modification by DMS, CMCT or NMIA and control reaction without mapping reagents and resolved in two capillaries (reaction and control) with ddNTP ladders. Primers labeled with 5-JOE were used for ddNTP ladders (most often ddATP). The experiments were performed in at least technical triplicate with the average results presented. For obtained reactivity of each nucleotide the standard deviation (SD) is calculated (<xref ref-type="supplementary-material" rid="SD2">Supporting_Information_1</xref>).</p>
</sec>
<sec id="S14">
<title>Processing of chemical mapping data</title>
<p id="P20">QuShape program was used to analyze mapping data according to published method [<xref ref-type="bibr" rid="R46">46</xref>]. NMIA reactivities was normalized by QuShape program using model-free statistics to a scale spanning 0 to ~2, where zero indicates no reactivity and 1.0 is the lowaverage intensity for highly reactive RNA positions [<xref ref-type="bibr" rid="R46">46</xref>]. Nucleotides with normalized SHAPE reactivities 0–0.5, 0.5–0.7, and &gt;0.7 correspond to unreactive, moderately reactive, and highly reactive positions, respectively. Nucleotides with no data were designated as –999. Normalized SHAPE reactivities from extension reaction of each primer were processed independently. DMS and CMCT modifications analysis was conducted similar to NMIA reactivity calculations, except that only strong modification were used in RNAstructure prediction.</p>
<p id="P21">Chemical mapping results were used in the RNAstructure [<xref ref-type="bibr" rid="R47">47</xref>] for prediction of secondary structure of sgRNA M. Normalized SHAPE reactivity (as described above) was used in RNAstructure 6.2 through “Read SHAPE reactivity—pseudo free energy” mode with slope 1.8 and intercept –0.6kcal/mol [<xref ref-type="bibr" rid="R48">48</xref>]. DMS and CMCT strong reactivities were introduced in the same prediction using “chemical modification” mode [<xref ref-type="bibr" rid="R49">49</xref>].</p>
</sec>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Suporting Information_2</label>
<media xlink:href="EMS136600-supplement-Suporting_Information_2.docx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" id="N66271" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>Supporting_Information_1</label>
<media xlink:href="EMS136600-supplement-Supporting_Information_1.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="N66280" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S15">
<title>Funding</title>
<p>This work was supported by National Science Centre grants UMO-2020/01/0/NZ6/00137 to E.K.</p>
</ack>
<fn-group>
<fn id="FN1" fn-type="conflict">
<p id="P22">
<bold>Disclosure statement</bold>
</p>
<p id="P23">No potential conflict of interest was reported by the authors.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<label>[1]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gloster</surname>
<given-names>AT</given-names>
</name>
<etal/>
</person-group>
<article-title>Impact of COVID-19 pandemic on mental health: An international study</article-title>
<source>PLoS One</source>
<year>2020</year>
<month>December</month>
<volume>15</volume>
<issue>12</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0244809</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>[2]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rehman</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Shafique</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ihsan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Evolutionary trajectory for the emergence of novel coronavirus SARS-CoV-2</article-title>
<source>Pathogens</source>
<year>2020</year>
<volume>9</volume>
<issue>3</issue>
<pub-id pub-id-type="doi">10.3390/pathogens9030240</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>[3]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirtipal</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bharadwaj</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>SG</given-names>
</name>
</person-group>
<article-title>From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses</article-title>
<source>Infection, Genetics and Evolution</source>
<year>2020</year>
<volume>85</volume>
<pub-id pub-id-type="doi">10.1016/j.meegid.2020.104502</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>[4]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Olsthoorn</surname>
<given-names>RCL</given-names>
</name>
</person-group>
<article-title>Group-specific structural features of the 5’-proximal sequences of coronavirus genomic RNAs</article-title>
<source>Virology</source>
<year>2010</year>
<volume>401</volume>
<issue>1</issue>
<pub-id pub-id-type="doi">10.1016/j.virol.2010.02.007</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>[5]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arya</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Structural insights into SARS-CoV-2 proteins</article-title>
<source>Journal of Molecular Biology</source>
<year>2021</year>
<volume>433</volume>
<issue>2</issue>
<pub-id pub-id-type="doi">10.1016/j.jmb.2020.11.024</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>[6]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>YJ</given-names>
</name>
</person-group>
<article-title>The outbreak of COVID-19: An overview</article-title>
<source>Journal of the Chinese Medical Association</source>
<year>2020</year>
<volume>83</volume>
<issue>3</issue>
<pub-id pub-id-type="doi">10.1097/JCMA.0000000000000270</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>[7]</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Fehr</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Perlman</surname>
<given-names>S</given-names>
</name>
</person-group>
<chapter-title>Coronaviruses: An overview of their replication and pathogenesis</chapter-title>
<source>Coronaviruses: Methods and Protocols</source>
<year>2015</year>
</element-citation>
</ref>
<ref id="R8">
<label>[8]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>V’kovski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kratzel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Stalder</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Thiel</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Coronavirus biology and replication: implications for SARS-CoV-2</article-title>
<source>Nature Reviews Microbiology</source>
<year>2021</year>
<volume>19</volume>
<issue>3</issue>
<pub-id pub-id-type="doi">10.1038/s41579-020-00468-6</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>[9]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ruggiero</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Squeglia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Maga</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Berisio</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping</article-title>
<source>Cells</source>
<year>2020</year>
<volume>9</volume>
<issue>5</issue>
<pub-id pub-id-type="doi">10.3390/cells9051267</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>[10]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>VN</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The Architecture of SARS-CoV-2 Transcriptome</article-title>
<source>Cell</source>
<year>2020</year>
<volume>181</volume>
<issue>4</issue>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.04.011</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>[11]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hartenian</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nandakumar</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lari</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ly</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Glaunsinger</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>The molecular virology of coronaviruses</article-title>
<source>Journal of Biological Chemistry</source>
<year>2020</year>
<volume>295</volume>
<issue>37</issue>
<pub-id pub-id-type="doi">10.1074/jbc.REV120.013930</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>[12]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nomburg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meyerson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>DeCaprio</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2</article-title>
<source>Genome Med</source>
<year>2020</year>
<volume>12</volume>
<issue>1</issue>
<pub-id pub-id-type="doi">10.1186/s13073-020-00802-w</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>[13]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sola</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Almazán</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zúñiga</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Enjuanes</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Continuous and Discontinuous RNA Synthesis in Coronaviruses</article-title>
<source>Annual Review of Virology</source>
<year>2015</year>
<volume>2</volume>
<pub-id pub-id-type="doi">10.1146/annurev-virology-100114-055218</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>[14]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thiel</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>
<article-title>Mechanisms and enzymes involved in SARS coronavirus genome expression</article-title>
<source>Journal of General Virology</source>
<year>2003</year>
<volume>84</volume>
<issue>9</issue>
<pub-id pub-id-type="doi">10.1099/vir.0.19424-0</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>[15]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiening</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ochsenreiter</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hellinger</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Rattei</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hofacker</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Frishman</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Conserved secondary structures in viral mRNAs</article-title>
<source>Viruses</source>
<year>2019</year>
<volume>11</volume>
<issue>5</issue>
<pub-id pub-id-type="doi">10.3390/v11050401</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>[16]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Cesaris Araujo Tavares</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mahadeshwar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Huston</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Pyle</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>The Global and Local Distribution of RNA Structure throughout the SARS-CoV-2 Genome</article-title>
<source>J Virol</source>
<year>2020</year>
<volume>95</volume>
<issue>5</issue>
<pub-id pub-id-type="doi">10.1128/jvi.02190-20</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>[17]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rangan</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: A first look</article-title>
<source>RNA</source>
<year>2020</year>
<volume>26</volume>
<issue>8</issue>
<pub-id pub-id-type="doi">10.1261/RNA.076141.120</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>[18]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrews</surname>
<given-names>RJ</given-names>
</name>
<etal/>
</person-group>
<article-title>An in silico map of the SARS-CoV-2 RNA Structurome</article-title>
<source>bioRxiv</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.04.17.045161</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>[19]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simmonds</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Pervasive RNA secondary structure in the genomes of SARS-CoV-2 and other coronaviruses</article-title>
<source>MBio</source>
<year>2020</year>
<volume>11</volume>
<issue>6</issue>
<pub-id pub-id-type="doi">10.1128/mBio.01661-20</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>[20]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vandelli</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Structural analysis of SARS-CoV-2 genome and predictions of the human interactome</article-title>
<source>Nucleic Acids Res</source>
<year>2020</year>
<volume>48</volume>
<issue>20</issue>
<pub-id pub-id-type="doi">10.1093/nar/gkaa864</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>[21]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manfredonia</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group>
<article-title>Genome-wide mapping of SARS-CoV-2 RNA structures identifies therapeutically-relevant elements</article-title>
<source>Nucleic Acids Res</source>
<year>2020</year>
<volume>48</volume>
<issue>22</issue>
<pub-id pub-id-type="doi">10.1093/nar/gkaa1053</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>[22]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lan</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Structure of the full SARS-CoV-2 RNA genome in infected cells</article-title>
<source>bioRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R23">
<label>[23]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs</article-title>
<source>Cell</source>
<year>2021</year>
<volume>184</volume>
<issue>7</issue>
<pub-id pub-id-type="doi">10.1016/j.cell.2021.02.008</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>[24]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>Comparative analysis of coronavirus genomic RNA structure reveals conservation in SARS-like coronaviruses</article-title>
<source>bioRxiv</source>
<year>2020</year>
<pub-id pub-id-type="doi">10.1101/2020.06.15.153197</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>[25]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>
<article-title>Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions</article-title>
<source>bioRxiv</source>
<year>2021</year>
</element-citation>
</ref>
<ref id="R26">
<label>[26]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ehresmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baudin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mougel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Romby</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ebel</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Ehresmann</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Probing the structure of RNAs in solution</article-title>
<source>Nucleic Acids Res</source>
<year>1987</year>
<volume>15</volume>
<issue>22</issue>
<fpage>9109</fpage>
<lpage>9128</lpage>
<pub-id pub-id-type="doi">10.1093/nar/15.22.9109</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>[27]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merino</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Coughlan</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Weeks</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>RNA structure analysis at single nucleotide resolution by Selective 2’-Hydroxyl Acylation and Primer Extension (SHAPE)</article-title>
<source>J Am Chem Soc</source>
<year>2005</year>
<volume>127</volume>
<issue>12</issue>
<fpage>4223</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1021/ja043822v</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>[28]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ziehler</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Engelke</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Probing RNA Structure with Chemical Reagents and Enzymes</article-title>
<source>Curr Protoc Nucleic Acid Chem</source>
<year>2000</year>
<volume>00</volume>
<issue>1</issue>
<fpage>6.1.1</fpage>
<lpage>6.1.21</lpage>
<pub-id pub-id-type="doi">10.1002/0471142700.nc0601s00</pub-id>
</element-citation>
</ref>
<ref id="R29">
<label>[29]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>ZJ</given-names>
</name>
<name>
<surname>Gloor</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Mathews</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Improved RNA secondary structure prediction by maximizing expected pair accuracy</article-title>
<source>RNA</source>
<year>2009</year>
<volume>15</volume>
<issue>10</issue>
<pub-id pub-id-type="doi">10.1261/rna.1643609</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>[30]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miao</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Tidu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eriani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Secondary structure of the SARS-CoV-2 5’-UTR</article-title>
<source>RNA Biol</source>
<year>2021</year>
<volume>18</volume>
<issue>4</issue>
<pub-id pub-id-type="doi">10.1080/15476286.2020.1814556</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>[31]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wacker</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy</article-title>
<source>Nucleic Acids Res</source>
<year>2020</year>
<volume>48</volume>
<issue>22</issue>
<pub-id pub-id-type="doi">10.1093/nar/gkaa1013</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>[32]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ziv</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>
<article-title>The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2</article-title>
<source>Mol Cell</source>
<year>2020</year>
<volume>80</volume>
<issue>6</issue>
<pub-id pub-id-type="doi">10.1016/j.molcel.2020.11.004</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>[33]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Structural Lability in Stem-Loop 1 Drives a 5’ UTR-3’ UTR Interaction in Coronavirus Replication</article-title>
<source>J Mol Biol</source>
<year>2008</year>
<volume>377</volume>
<issue>3</issue>
<pub-id pub-id-type="doi">10.1016/j.jmb.2008.01.068</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>[34]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Millership</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Leibowitz</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Giedroc</surname>
<given-names>DP</given-names>
</name>
</person-group>
<article-title>A U-turn motif-containing stem-loop in the coronavirus 5’ untranslated region plays a functional role in replication</article-title>
<source>RNA</source>
<year>2007</year>
<volume>13</volume>
<issue>5</issue>
<pub-id pub-id-type="doi">10.1261/rna.261807</pub-id>
</element-citation>
</ref>
<ref id="R35">
<label>[35]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Khadijah</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tay</surname>
<given-names>FPL</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>DX</given-names>
</name>
</person-group>
<article-title>The Cellular RNA Helicase DDX1 Interacts with Coronavirus Nonstructural Protein 14 and Enhances Viral Replication</article-title>
<source>J Virol</source>
<year>2010</year>
<volume>84</volume>
<issue>17</issue>
<pub-id pub-id-type="doi">10.1128/jvi.00392-10</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>[36]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vlachogiannis</surname>
<given-names>NI</given-names>
</name>
<name>
<surname>Verrou</surname>
<given-names>K-M</given-names>
</name>
<name>
<surname>Stellos</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sfikakis</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Paraskevis</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection</article-title>
<source>Clin Immunol</source>
<year>2021</year>
<volume>226</volume>
<pub-id pub-id-type="doi">10.1016/j.clim.2021.108699</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>[37]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarkar</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Bandyopadhyay</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>GC</given-names>
</name>
</person-group>
<article-title>Enzymatic characteristics of recombinant medium isozyme of 2’-5’ oligoadenylate synthetase</article-title>
<source>J Biol Chem</source>
<year>1999</year>
<volume>274</volume>
<issue>3</issue>
<pub-id pub-id-type="doi">10.1074/jbc.274.3.1848</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>[38]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarkar</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>GC</given-names>
</name>
</person-group>
<article-title>The nature of the catalytic domain of 2’-5’-oligoadenylate synthetases</article-title>
<source>J Biol Chem</source>
<year>1999</year>
<volume>274</volume>
<issue>36</issue>
<pub-id pub-id-type="doi">10.1074/jbc.274.36.25535</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>[39]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcription</article-title>
<source>Cell Host Microbe</source>
<year>2014</year>
<volume>16</volume>
<issue>4</issue>
<pub-id pub-id-type="doi">10.1016/j.chom.2014.09.009</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>[40]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ponti</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Armaos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vandelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tartaglia</surname>
<given-names>GG</given-names>
</name>
</person-group>
<article-title>CROSSalive: A web server for predicting the in vivo structure of RNA molecules</article-title>
<source>Bioinformatics</source>
<year>2020</year>
<volume>36</volume>
<issue>3</issue>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btz666</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>[41]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Groot</surname>
<given-names>NS</given-names>
</name>
<etal/>
</person-group>
<article-title>RNA structure drives interaction with proteins</article-title>
<source>Nat Commun</source>
<year>2019</year>
<volume>10</volume>
<issue>1</issue>
<pub-id pub-id-type="doi">10.1038/s41467-019-10923-5</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>[42]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cid-Samper</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>An Integrative Study of Protein-RNA Condensates Identifies Scaffolding RNAs and Reveals Players in Fragile X-Associated Tremor/Ataxia Syndrome</article-title>
<source>Cell Rep</source>
<year>2018</year>
<volume>25</volume>
<issue>12</issue>
<pub-id pub-id-type="doi">10.1016/j.celrep.2018.11.076</pub-id>
</element-citation>
</ref>
<ref id="R43">
<label>[43]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerase</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Armaos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Neumayer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Avner</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Guttman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tartaglia</surname>
<given-names>GG</given-names>
</name>
</person-group>
<article-title>Phase separation drives X-chromosome inactivation: a hypothesis</article-title>
<source>Nature Structural and Molecular Biology</source>
<year>2019</year>
<volume>26</volume>
<issue>5</issue>
<pub-id pub-id-type="doi">10.1038/s41594-019-0223-0</pub-id>
</element-citation>
</ref>
<ref id="R44">
<label>[44]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kierzek</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kierzek</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The thermodynamic stability of RNA duplexes and hairpins containing N6-alkyladenosines and 2-methylthio-N6-alkyladenosines</article-title>
<source>Nucleic Acids Res</source>
<year>2003</year>
<volume>31</volume>
<issue>15</issue>
<pub-id pub-id-type="doi">10.1093/nar/gkg633</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>[45]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>Thermodynamic parameters for an expanded nearest-neighbor model for formation of RNA duplexes with Watson - Crick base pairs</article-title>
<source>Biochemistry</source>
<year>1998</year>
<volume>37</volume>
<issue>42</issue>
<pub-id pub-id-type="doi">10.1021/bi9809425</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>[46]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karabiber</surname>
<given-names>F</given-names>
</name>
<name>
<surname>McGinnis</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Favorov</surname>
<given-names>OV</given-names>
</name>
<name>
<surname>Weeks</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>QuShape: Rapid, accurate, and best-practices quantification of nucleic acid probing information, resolved by capillary electrophoresis</article-title>
<source>RNA</source>
<year>2013</year>
<volume>19</volume>
<issue>1</issue>
<fpage>63</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1261/rna.036327.112</pub-id>
</element-citation>
</ref>
<ref id="R47">
<label>[47]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reuter</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Mathews</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>RNAstructure: Software for RNA secondary structure prediction and analysis</article-title>
<source>BMC Bioinformatics</source>
<year>2010</year>
<volume>11</volume>
<pub-id pub-id-type="doi">10.1186/1471-2105-11-129</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>[48]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deigan</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Mathews</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Weeks</surname>
<given-names>KM</given-names>
</name>
</person-group>
<article-title>Accurate SHAPE-directed RNA structure determination</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2009</year>
<volume>106</volume>
<issue>1</issue>
<pub-id pub-id-type="doi">10.1073/pnas.0806929106</pub-id>
</element-citation>
</ref>
<ref id="R49">
<label>[49]</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathews</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Disney</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Childs</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Zuker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2004</year>
<volume>101</volume>
<issue>19</issue>
<fpage>7287</fpage>
<lpage>7292</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0401799101</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>sgRNA M model predicted by RNAstructure 6.2 using experimental data as constraints. Strong DMS and CMCT modifications, as well as SHAPE reactivities converted to pseudo-free energies were used. The numbering of sgRNA M is from its 5’ end. The AUG start codon spans nucleotides 120–122. Red nucleotides indicate TRS sequences. Hairpins SL1, SL2 and SL3 are indicated.</p>
</caption>
<graphic xlink:href="EMS136600-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Predicted probability of nucleotides being paired or single stranded in sgRNA M using RNAstructure program. Probability lower than 50% is not colored. The partition function calculation incorporated restraints from strong reactivity of DMS and CMCT as well as SHAPE reactivities converted to pseudo-energies.</p>
</caption>
<graphic xlink:href="EMS136600-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Comparison of secondary structure of sgRNA M and its corresponding region of SARS-CoV-2 genome mapped in-cells. Blue rectangle indicates the same base pairs within sgRNA M model and corresponding region of SARS-CoV-2 genome mapped in-cells [<xref ref-type="bibr" rid="R22">22</xref>]. Yellow rectangle indicates motifs of leader sequence.</p>
</caption>
<graphic xlink:href="EMS136600-f003"/>
</fig>
<table-wrap id="T1" position="float" orientation="portrait">
<label>Table 1</label>
<caption>
<title>Primers for polymerase chain reaction using to obtain DNA template for sgRNA M. The underlined nucleotides residues are the polymerase T7 promoter.</title>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="center" valign="middle">name</th>
<th align="center" valign="middle">length (nt)</th>
<th align="center" valign="middle">Sequence 5’→3’</th>
</tr>
</thead>
<tbody>
<tr>
<td align="right" valign="middle">FM</td>
<td align="right" valign="bottom">46</td>
<td align="left" valign="middle">GCGT<underline>AATACGACTCACTATA</underline>GGGATTAAAGGTTTATACCTTCCCAG</td>
</tr>
<tr>
<td align="right" valign="middle">RM</td>
<td align="right" valign="bottom">29</td>
<td align="left" valign="middle">TTACTGTACAAGCAAAGCAATATTGTCAC</td>
</tr>
<tr>
<td align="right" valign="middle">F1</td>
<td align="right" valign="bottom">54</td>
<td align="left" valign="middle">CTTGTAGATCTGTTCTCTAAACGAACTAAATATTATATTAGTTTTTCTGTTTGG</td>
</tr>
<tr>
<td align="right" valign="middle">F2</td>
<td align="right" valign="bottom">48</td>
<td align="left" valign="middle">GTAACAAACCAACCAACTTTCGATCTCTTGTAGATCTGTTCTCTAAAC</td>
</tr>
<tr>
<td align="right" valign="middle">F3</td>
<td align="right" valign="bottom">45</td>
<td align="left" valign="middle">ATTAAAGGTTTATACCTTCCCAGGTAACAAACCAACCAACTTTCG</td>
</tr>
<tr>
<td align="right" valign="middle">FC</td>
<td align="right" valign="bottom">29</td>
<td align="left" valign="middle">TTCTGCAGATTAAAGGTTTATACCTTCCC</td>
</tr>
<tr>
<td align="right" valign="middle">RC</td>
<td align="right" valign="bottom">37</td>
<td align="left" valign="middle">ATGAATTCTTACTGTACAAGCAAAGCAATATTGTCAC</td>
</tr>
<tr>
<td align="right" valign="bottom">13F</td>
<td align="right" valign="bottom">24</td>
<td align="left" valign="middle">CGCCAGGGTTTTCCCAGTCACGAC</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float" orientation="portrait">
<label>Table 1</label>
<caption>
<title>Primers for reverse transcription. Each primer was labeled with 5-FAM or 6-JOE at 5’ end.</title>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" valign="middle">name</th>
<th align="left" valign="middle">length (nt)</th>
<th align="center" valign="middle">Sequence 5’→3’</th>
</tr>
</thead>
<tbody>
<tr>
<td align="right" valign="middle">M1</td>
<td align="right" valign="middle">27</td>
<td align="left" valign="middle">TTACTGTACAAGCAAAGCAATATTGTC</td>
</tr>
<tr>
<td align="right" valign="middle">M2</td>
<td align="right" valign="middle">21</td>
<td align="left" valign="middle">CAGCTCCGATTACGAGTTCAC</td>
</tr>
<tr>
<td align="right" valign="middle">M3</td>
<td align="right" valign="middle">24</td>
<td align="left" valign="middle">CAAGCTAAAGTTACTGGCCATAAC</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
